// App-Quantinova.ai

THU0206 : CLINICAL USEFULNESS OF SERUM LEVEL OF ADALIMUMAB, IN PATIENTS WITH RHEUMATOID ARTHRITIS

Researchers

Presenter

  • J. Rosas

Principal Investigators

  • F. Llinares

  • I. De La Torre

  • M. Sanchez-Barrioluengo

  • J. Molina-Garcia

  • L. Valor

  • X. Barber

  • C. Santos-Ramirez

  • D. Hernandez

  • J. M. Senabre

  • L. Carreno

  • G. Santos-Soler

  • E. Salas

Medical Centers

  • Ingenio CSIC-UPV, Universitat Politecnica de Valencia, Valencia, Spain

Locations

  • Spain

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Rheumatoid arthritis

Biomarkers

  • N/A

Drug/Treatment

  • Hydroxychloroquine

  • Methotrexate

  • HWA-486

  • Adalimumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved